Hematopoiesis is a complex process requiring multiple regulators for hematopoietic stem/progenitor cells (HSPC) and differentiation to multi-lineage blood cells. TC1(C8orf4) is implicated in cancers, hematological malignancies and inflammatory activation. Here, we report that Tc1 regulates hematopoiesis in mice. Myeloid and lymphoid cells are increased markedly in peripheral blood of Tc1-deleted mice compared to wild type controls. Red blood cells are small-sized but increased in number. The bone marrow of Tc1 2/2 mice is normocellular histologically. However, Lin 
Introduction
Hematopoiesis is a well orchestrated complex process under tight regulation. Numerous mature blood cells of multiple distinct lineage are produced everyday from small number of hematopoietic stem cells (HSC) (reviewed in [1] [2] [3] ). The lineage fate is controlled in large part by distinct sets of transcriptional factors that may function independently or in combinations (reviewed in [4] [5] [6] ). Bone marrow cytokines also play an important role in the hematopoietic regulation (reviewed in [7] ). The regulation of hematopoietic stem/progenitor cells (HSPC) and hematopoiesis is one of the most extensively studied in biomedical science, including numerous animal studies in vivo [8] . However, our understanding of the complex regulation is still limited, and more regulators may wait to be identified.
TC1(C8orf4) is well conserved among vertebrates. It has been implicated in various cancers [9] [10] [11] [12] [13] . In stomach cancers, it has been implicated in poor prognosis of patients [12] . The copy number variation of TC1 is associated with acute myeloid leukemia and other hematological malignancies [14, 15] , suggesting a potential role in the hematopoietic regulation. In zebrafish embryos, two homologues are expressed in association with hematopoietic cells and blood vessels, respectively [16] .
TC1 is a natively disordered protein [10] , and undergoes rapid proteosomal degradation [17] . The expression is enhanced by proinflammatory cytokines, heat shock, and various cellular stresses [18, 19] . It enhances Wnt/b-catenin signaling in cancer cells and is associated with poor prognosis [12, 17] . It also induces inflammatory activation of endothelial cells enhancing classical NF-kB signaling [16] . It regulates the expression of pro-inflammatory downstream genes, suggesting a role of transcriptional regulator [12, 16, 17] . It has recently been implicated in Parkinson's disease in a genome-wide association study (GWAS), suggesting an aberrant regulation of innate immunity and/or blood vessels in brain [20] .
To investigate the biological role in vivo, we have constructed a gene-targeted mouse line. Here, we report a novel role of Tc1 as a hematopoietic regulator.
Materials and Methods

Mice
Tc1-targeted mice were developed using a neomycinR inserted targeting construct transfected to the 129 strain ES cell. They have been backcrossed to C57BL/6 mice for 10 generations in specific pathogen-free (SPF) animal facility at the Asan Institute for Life Sciences, Seoul, Korea. All animal studies were performed with the approval by the Animal Care and Use Committee of the Asan Institute for Life Sciences following the experimental guidelines (Permit Number: 2012-12-054).
Peripheral blood cell analysis
Peripheral blood samples were obtained from anesthetized mice by inferior vena cava puncture using a 26 gauge needle and 1 mL 
Bone marrow cell separation
Bone marrow cells were flushed from femurs and tibias and filtrated through a cell strainer with 100-mm nylon mesh (BD Biosciences, San Jose, CA). Lineage-negative cells were obtained using a Lineage Cell Depletion Kit covering Ter119, Gr-1, CD11b, CD41, CD3e, and B220 (Miltenyi Biotec, Gladbach, Germany). Lin 2 Sca-1 + cells were sorted from Sca-1 stained Lin 2 fraction using by FACSCalibur (BD Biosciences) flow cytometer as indicated.
Colony-forming unit assay
Bone marrow cells obtained through flushing femurs and tibias using Iscove's Modified Dulbecco's Medium with 2% FBS (Life Technologies, Carlsbad, CA). Three independent experiments were done in duplicates and plated on dual-chamber slides. For CFU-GM, CFU-GEMM and BFU-E assay, 2610 4 cells were plated in 35-mm dish of MethoCult GF M3434 with recombinant mouse SCF, rmIL-3, recombinant human IL-6 and rhEpo. For 5 cells were plated with rhEpo, according to manufacturer's instructions (StemCell Technologies, Vancouver, BC, Canada). Colonies were blindly scored using microscope after 2 days of culture at 37uC with 5% CO 2 and 95% humidity for CFU-E and at 7-12 days for CFU-GM, CFU-GEMM and BFU-E. Cells were harvested from plates with CFU colonies for flow cytometry. For repeated plating analysis, 1610 4 Lin 2 cells were re-plated on MethoCult GF M3434 agar similarly up to 3 times.
Flow cytometry
Single-cell suspension was prepared in ice-cold PBS containing 5% FBS, and 10 6 cells were analyzed with 1mg antibody using FACSCantoII (BD Biosciences) flow cytometer. FITC-conjugated anti-CD11b, PE-conjugated F4/80 (BD Biosciences), FITCconjugated Sca-1, PE-conjugated c-Kit (BD Biosciences), Alexa Fluor 647-conjugated Pu.1 (Cell Signaling Technology, Danvers, MA), APC-conjugated anti mouse CD150 and PerCP-conjugated anti CD48 antibodies (eBioscience Inc, San Diego, CA) were used as indicated. For Tc1 immunostaining, cells were fixed for 20 min at 4uC using Cytofix/Cytoperm kit (BD Biosciences). Anti-Tc1 antibody (Santa Cruz Biotechnology) and Alexa Fluor 594-or 488-conjugated anti-rabbit IgG secondary antibodies (Molecular Probes Inc, Eugene, OR) were applied sequentially after washing. FACSDiva software (BD Biosciences) and FlowJo (Tree Star) were used for data acquisition and analysis.
Confocal immunofluorescence microscopy 1.2610 5 cells suspended in PBS were cytocentrifuged x1,000 rpm for 1 min onto glass slide. Slides were air-dried at room temperature and fixed in 100% methanol for 10 min at 2 20uC. Cells were immunostained using anti-Tc1 antibody (1:50 dilution) for 3 h. After washing with PBS, Alexa Fluor 594-conjugated anti-rabbit IgG secondary antibody was applied in 1:200 dilution for 1 h. Nuclear staining was done using Hoechst 33342 (Sigma-Aldrich). Cells were viewed using an inverted zeiss LSM 710 confocal microscopy (Carl Zeiss, Thornwood, NY).
Cytokine array and western blotting
For cytokine array, flushed bone marrow cells were gently washed with serum-free RPMI 1640 (Gibco, Carlsbad, CA) media for 10 min at room temperature, and the media was recovered by centrifugation at 300 g for 5 min. 250 mg of total proteins measured by Bradford assay were applied to a mouse cytokine array (Raybiotech, Norcross, GA), as described previously (16) . For western blotting, total tissue samples were solubilized in lysis buffer, and loaded, 20 mg per lane, on 12% SDS-PAGE. Proteins were blotted onto nitrocellulose membrane and probed using anti-TC1 antibody. Anti-b-actin antiserum was used for loading control (Sigma-Aldrich).
Quantitative RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA), and cDNA was synthesized using Premium reverse transcriptase (Thermo Scientific, Marietta, OH). qPCR was performed using a continuous fluorescence detecting thermal cycler ABI PRISM 7000 Sequence Detection System (ABI, Foster city, CA), and a SYBR Green real-time PCR master mix (Toyobo, Osaka, Japan). Measurements were done in triplicate using b-actin as endogenous control. PCR primers are summarized in Table 1 .
TC1-transfected HL-60 cells
HL-60 cells were cultured in RPMI media, supplemented with 10% FBS and 100U/ml penicillin and 100 mg/ml streptomycin (Gibco), at 37uC in humidified atmosphere with 5% CO 2 . 1610 7 of HL-60 cells at passages 4-8 were harvested in the exponential growth phase and resuspended in Gene Pulser Electroporation buffer (Bio-Rad, Hercules, CA). Cells were mixed with TC1-pCAGGS mammalian expression vector (Addgene, Cambridge, MA) or vectors only, and pulsed at 175V, 1000 mF using 4 mm cuvette by Gene Pulser Xcell Electroporation Systems (Bio-Rad).
Statistical Methods
All measurements are presented as the mean 6 s.d. Statistical analyses were performed by two-tailed t -tests by SPSS version 20 (SPSS Inc., Chicago, IL).
Results
Myeloid and lymphoid hyperplasia in Tc1
2/2 mice blood Tc1-targeted mice were generated ( Figure 1 and Figure S1 ), and were back-crossed to C57BL/6 mice for 10 generations. Systemic deletion in homozygotes was confirmed by RT-PCR ( Figure S2 ) and western blotting (data not shown). Tc1-deleted homozygotes have thrived under the SPF environment. Interestingly, the hematological profile changed remarkably.
Peripheral blood total WBC increased in young adult Tc1 2/2 mice compared to age-, and sex-matched wild type controls by 56.3% in average (p,0.001, Figure 2A ). Neutrophils increased predominantly, 2.8 times of controls in average. Lymphocytes also increased by 44.1% in average. However, the percentage of lymphocytes in total WBC was rather decreased by 11.1% (p, 0.001, Figure 2B ), reflecting steeper increase of myeloid cells including neutrophils, monocytes, and eosinophils (Figure 2A, C) . The expression of Cd11b and F4/80, myeloid and macrophage/ We then investigated whether WBCs of Tc1 2/2 mice were functionally active. Trem-1 is selectively expressed on activated neutrophils and monocytes to amplify the inflammatory response [21] . Trem-1 was up-regulated in blood mononuclear cells of Tc1 2/2 mice compared to controls by qPCR analysis ( Figure 2E , left), suggesting that they were no less active than the wild type counterparts. To investigate a role of TC1 on the TREM-1 expression, human promyelocytic leukemia cell line HL-60 was transiently transfected with TC1 using electroporation. TREM-1 was down-regulated in TC1-transfected HL-60 cells compared to vector-transfected control ( Figure 2E, right) , suggesting a potential role of TC1 in regulating myeloid cell activity.
Increased number of small-sized RBCs in Tc1
2/2 mice
Red blood cells (RBC) also increased in Tc1 2/2 mice by 6.86% in average compared to controls (p,0.001, Figure 2F ). However, the mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) decreased significantly, indicating that RBCs of Tc1 2/2 mice were smaller than controls. The hematocrit (HCT; Figure 2F ) and mean corpuscular hemoglobin concentration (MCHC; data not shown) remained unchanged. No abnormal RBC was shown on blood smear (data not shown). The red cell distribution width (RDW), reflecting the RBC size variation, was higher in Tc1 2/2 mice than controls ( Figure 2F , right).
Expansion of LSK cells in Tc1 2/2 mice
The bone marrow of Tc1 2/2 mice showed normal cellularity, composition, and bone development (not shown). The lineagenegative bone marrow cells were analyzed using flow cytometry. Lin 2 Sca-1 + c-Kit + (LSK) cells were expanded in Tc1 2/2 mice bone marrow compared to controls (Figure 3) , suggesting a role of Tc1 in the HSPC regulation. LSK cells were gated and further analyzed for CD150/Cd48 profiling [22, 23] 
Tc1 expression in primitive hematopoietic cells
The expression of Tc1 in wild type C57BL/6 mouse bone marrow was investigated. Previously, TC1 has been reported to express at low level in bone marrow of humans and zebrafish embryos [9, 16] , while the expression in peripheral blood is too low to be detected by RNA blotting [9, 17] . Upon immunofluorescence microscopy, Tc1 was expressed in small numbers of primitive hematopoietic cells. HSC-like cells with round nuclei of 6-8 mM in diameter and scant cytoplasm showed relatively weak cytoplasmic granular staining ( Figure 4A, upper panel) . Large progenitor-like cells often showed strong cytoplasmic and faint nuclear staining ( Figure 4A , lower panel). The nuclear translocation of TC1 upon cellular stimuli was described, suggesting a role in the regulation of downstream gene expression [19] . Cells with ring-shaped nuclei were also immunostained for Tc1 ( Figure S3A, B) . Myeloid cells with ring-shaped nuclei were reported in mouse but not in humans normally [24] . Differentiated myeloid cells were not immunostained ( Figure S3B, C) .
Tc1 expression in lineage-negative bone marrow cells was investigated using flow cytometry. Tc1-expressing cells were infrequent, much less than 1% of total Lin 2 cells ( Figure 4B ). Tc1
+ cells mostly co-expressed Sca-1. Tc1 expression was further analyzed in gated cells according to CD150/CD48 profiles. Most CD150 + CD48 2 cells were positive for Tc1, supporting the expresssion of Tc1 by HSCs ( Figure 4B ) [22, 23] . Tc1 was also expressed in significant proportions of CD150 2 CD48 + and CD150 + CD48 + cells, corresponding to lineage-restricted progenitor cells [22, 23] .
Increased colony forming units in Tc1
2/2 mice bone marrow
We investigated the hematopoietic activity of lineage-negative cells from Tc1 2/2 and wild type mice bone marrow using colony forming unit (CFU) assay. CFU-granulocyte-macrophage(GM) and CFU-granulocyte-erythroid-monocyte-megakaryocyte(-GEMM) increased in Tc1 2/2 mice compared to controls ( Figure 5A , B and Figure S4 ). CFU-E also increased significantly in Tc1 2/2 mice ( Figure 5C ). Burst-forming unit(BFU)-E, which represent erythroid hematopoietic activity at upper hierarchy, did not increase compared to controls ( Figure 5D ). Total CFU-GM containing cells were recovered and analyzed using flow cytometry. The profiles of Sca-1, c-Kit, CD150, and CD48 expression were similar between Tc1 2/2 and wild type mice ( Figure 5E ). CD11b and F4/80 expressing cells appeared to be mildly increased in Tc1 2/2 colonies compared to controls, suggesting up-regulated potential for myelopoiesis.
To investigate the self-renewal activity, we serially re-plated cells applying the same number of cells to each plate similarly. The colony forming activities were maintained on repeated plating in cells from Tc1 2/2 and wild type mice ( Figure S5 ). Colonies from Tc1 2/2 mice bone marrow appeared to be less than wild type controls upon re-plating, probably reflecting relatively reduced proportions of HSC compared to expanded myeloid progenitors in the given number of repeatedly plated cells.
Unknown mechanism for lineage regulation
Our data together supported a biological role of Tc1 in the regulation of HSPC in vivo. However, it was not clear how the relatively myeloid-and lymphoid-prone lineage fate was determined in Tc1 2/2 mice. We first investigated the expression of major transcriptional regulators for myelopoiesis [25] . Upon flow cytometry, the expression of Pu.1 was not increased in LSK cells of Tc1 2/2 mice compared to wild type controls (data not shown). By qPCR analysis, Pu.1 was down-regulated significantly in total Lin 2 from Tc1 2/2 mice bone marrow compared to controls ( Figure 6A ). Pu.1 expression was also down-regulated in sorted Lin 2 Sca-1 + cells of Tc1 2/2 mice. To investigate a potential TC1-dependent regulation of PU.1, HL-60 cells were transfected using TC1. No significant change in the PU.1 expression was shown in TC1-transfected HL-60 cells compared to vector-transfected control (data not shown). Cebpa, another major regulator of myelopoiesis, was also down-regulated marginally (p,0.07) in Lin 2 cells of Tc1 2/2 mice compared to controls ( Figure 6B ). Gata-1, a major regulator for erythroid cell fate, appeared to be upregulated in Tc1 2/2 mice mildly, but the difference was not statistically significant ( Figure 6C ).
Hematopoietic cell lineages may also be regulated by cytokines [26, 27] . The expression of bone marrow cytokines was investigated using a cytokine array. No differentially expressed cytokine was detected in Tc1 2/2 mice compared to controls ( Figure S6 ). G-CSF and GM-CSF were not expressed enough to be detected. Upon qPCR of total bone marrow cells, the expression of G-CSF, GM-CSF, M-CSF, and Flt3l did not change in Tc1 2/2 mice compared to controls ( Figure S7 ).
Wnt signaling is normally required for the regulation of HSPC [28] . Using qPCR, we investigated the expression of c-Myc and Cyclin D1, typical downstream genes of classical Wnt signaling. cMyc was up-regulated significantly in Lin 2 cells of Tc1 2/2 mice compared to controls ( Figure 6D ). Cyclin D1 appeared to be upregulated mildly, but the difference was not statistically significant. c-Myc is one of the transcriptional regulators implicated in the regulation of pluripotent stem cells [29] . We investigated other regulators implicated in pluripotential stem cell induction including Klf4, Sox2, and Oct4. Klf4 was also up-regulated in Lin 2 bone marrow cells of Tc1 2/2 mice compared to controls ( Figure 6E ). Sox2 and Oct4 were not detected upon repeated qPCR analysis (data not shown).
Discussion
Tc1-deleted mice show increased blood cells and enhanced hematopoietic activity. LSK cells are expanded in vivo and CFUs are increased in vitro, supporting the role of Tc1 as a novel hematopoietic regulator. CD150
2 CD48 + cells are increased in gated LSK cells, supporting that lineage-restricted hematopoietic progenitor cells are expanded preferentially. Tc1 is expressed in a small population of hematopoietic cells including HSCs and lineage-restricted progenitor cells in wild type C57BL/6 mice bone marrow. Our data together supported a role of TC1 in negative hematopoietic regulation.
The hematopoietic activity is enhanced overall in Tc1 2/2 mice. Myeloid cells are expanded particularly, suggesting a potential role of Tc1 in the lineage fate determination. The mechanism of the skewed lineage regulation is not known. Myelopoietic transcriptional regulators Pu.1 and Cebpa are not up-regulated in hematopoietic cells from Tc1 2/2 mice compared to controls. Bone marrow cytokines such as G-CSF, GM-CSF, M-CSF, and Flt3l are not up-regulated, either. Further investigations are required for other transcriptional regulators, cytokines, and/or in vivo hematopoietic niche regulation.
Interestingly, RBCs are also expanded in number but smallsized in Tc1-deleted mice blood. The size of RBC may be influenced by environmental and genetic factors. RBCs of Phyllotis xanthopygus rupestris, a small Andean mammal, become significantly smaller during the winter whereas the hematocrit and total hemoglobin are not down-regulated [30] . The biological significance of small-sized RBCs is not clear. In humans, an ethnic difference in the RBC size has been reported in healthy individuals 2/2 mice, and 6 sex-and age-matched control mice over 3 independent experiments for the total Lin 2 cell assay, and 10 male, 8 to 9 week-old Tc1 2/2 mice, and 10 sex-and age-matched control mice over 2 independent experiments for the sorted-Lin without iron deficiency anemia [31] . Genetic determinants for RBC parameters have been sought for extensively using GWAS [32, 33] . As far as we are aware of, Tc1 is the first gene reported for definite RBC size determination. RBCs of Tc1-deleted mice also show increased size variation, RDW. Increased RDW is associated with cardiovascular and other adult diseases [34] . However, it is unknown whether it might be the cause or epiphenomenon of underlying diseases [35] .
TC1 has been implicated in the inflammatory activation of endothelial cells [16] . In mouse bone marrow, Tc1 was expressed by some myeloid cells with ring-shaped nuclei, which have been associated with myeloid-derived suppressor cells (MDSC) in mice [36] . TC1-dependent TREM-1 regulation in HL-60 cells suggests a potential role of TC1 in the regulation of leukocyte activity. Together, our data suggest that TC1 may have complex biological roles for systemic regulation of hematopoiesis, innate immunity, and stem cells in vertebrates. Author Contributions
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